|
Index of reports
> Cases resulting in hospitalization (56)
Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in hospitalization.
Reports 1 - 25 of 56 Next >>
Adverse event in 53 year old male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 53 year old male
Adverse reactions / side effects: Jaundice, Hepatitis B, Liver Disorder, Hepatitis Fulminant, Ascites
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Epzicom
Dosage: 1 dosage form= 1 tablet.
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-26
End date: 2006-09-28
Kaletra
Dosage: 4tablet/daily started from 27-oct-2006
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-26
End date: 2006-09-28
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Other drugs received by patient: Urso 250; Cinal S; Cellulase; Lipase; Lendormin; Ursodiol
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a individual with unspecified qualification from United States on 2007-10-19
Patient: female, weighing 0.9 kg (2.0 pounds)
Adverse reactions / side effects: Breech Delivery, Premature Baby, Congenital Anomaly, Patent Ductus Arteriosus, Joint Dislocation
Adverse event resulted in: hospitalization
Suspect drug(s):
3TC
Indication: HIV Infection
AZT
Indication: HIV Infection
Dexamethasone 0.5mg TAB
Epivir
Dosage: daily dose:300mg-freq:daily
Indication: HIV Infection
Fortovase
Dosage: daily dose:2400mg
Administration route: Oral
Indication: HIV Infection
Indocin
Retrovir
Dosage: daily dose:600mg-freq:daily
Administration route: Oral
Indication: HIV Infection
End date: 2003-03-12
Viracept
Dosage: daily dose:2500mg-freq:daily
Administration route: Oral
Indication: HIV Infection
Viramune
Dosage: daily dose:400mg-freq:daily
Indication: HIV Infection
Ziagen
Dosage: daily dose:600mg-freq:daily
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Videx
Adverse event in 44 year old male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-10-11
Patient: 44 year old male
Adverse reactions / side effects: Optic Atrophy, Glaucoma, Optic Nerve Disorder, Drug Ineffective, Tooth Abscess, Trigeminal Neuralgia, Sciatica, Tooth Extraction, Visual Acuity Reduced, Treatment Noncompliance, Balance Disorder, Leukoencephalopathy, Depression, Optic Neuritis Retrobulbar, Facial Pain, Mononeuropathy Multiplex, Visual Disturbance, Gastrointestinal Disorder, Memory Impairment, Neuralgia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Bactrim
Start date: 1998-09-01
Combivir
Indication: HIV Infection
Start date: 2005-09-28
End date: 2006-06-23
Epivir
Indication: HIV Infection
Start date: 1998-04-01
Invirase
Indication: HIV Infection
Start date: 2006-06-23
Lyrica
Indication: Trigeminal Neuralgia
Start date: 2006-06-23
End date: 2006-07-01
Neurontin
Indication: Trigeminal Neuralgia
Start date: 2006-01-01
End date: 2006-01-01
Norvir
Indication: HIV Infection
Start date: 2004-04-17
Retrovir
Indication: HIV Infection
Start date: 2006-06-23
Telzir
Indication: HIV Infection
Start date: 2005-03-29
End date: 2006-06-23
Viread
Indication: HIV Infection
Start date: 2006-06-23
Other drugs received by patient: Viracept; Zerit
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-10
Patient: male
Adverse reactions / side effects: Incorrect Dose Administered, Bone Marrow Failure, Drug Prescribing Error
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Adverse event in 45 year old male receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-07-31
Patient: 45 year old male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Pneumonia, Acute Respiratory Distress Syndrome, Pancytopenia, Histoplasmosis Disseminated, Pyrexia, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Crixivan
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-04
Daraprim
Administration route: Oral
Indication: Cerebral Toxoplasmosis
Start date: 2001-08-25
End date: 2001-08-31
Daraprim
Administration route: Oral
Start date: 2001-09-01
End date: 2001-09-06
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-04
Other drugs received by patient: Epivir; Clindamycin Hydrochloride; Dalacin S; Hydrocortone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Glyceol; Glyceol; Glyceol
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-30
Patient: female, weighing 3.9 kg (8.6 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Drug Administration Error, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Zidovudine
Adverse event in 52 year old male receiving Retrovir (Zidovudine)
Reported by a individual with unspecified qualification from France on 2007-07-26
Patient: 52 year old male
Adverse reactions / side effects: Weight Decreased, Hepatic Pain, Lactic Acidosis, Blood Lactic Acid Increased, Hepatic Steatosis, Myalgia, Hepatomegaly, Neck Pain, Anorexia, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir
Administration route: Oral
Indication: HIV Infection
End date: 2007-03-13
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-25
End date: 2007-03-13
Other drugs received by patient: Norvir; Prezista
Adverse event in 52 year old male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-24
Patient: 52 year old male
Adverse reactions / side effects: Weight Decreased, Hepatic Pain, Pain in Extremity, Lactic Acidosis, Hepatic Steatosis, Myalgia, Hepatomegaly, Gamma-Glutamyltransferase Increased, Neck Pain, Anorexia, Aspartate Aminotransferase Increased, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir
Administration route: Oral
Start date: 2006-07-24
End date: 2007-03-13
Viread
Administration route: Oral
Start date: 2002-09-25
End date: 2007-03-13
Other drugs received by patient: Norvir; Darunavir
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-24
Patient: female
Adverse reactions / side effects: Anaemia, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-24
Patient: female, weighing 2.6 kg (5.7 pounds)
Adverse reactions / side effects: NO Adverse Drug Reaction, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Adverse event in 2 month old male receiving Retrovir (Zidovudine)
Reported by a physician from France on 2007-07-16
Patient: 2 month old male
Adverse reactions / side effects: Gastrointestinal Malformation, Heart Disease Congenital, Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epivir
Start date: 2001-03-27
End date: 2001-08-11
Retrovir
Start date: 2001-03-27
End date: 2001-08-11
Videx
Start date: 2001-06-12
End date: 2001-08-11
Adverse event in 32 year old male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-07-13
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-13
Patient:
Adverse reactions / side effects: Drug Dependence
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Morphine
Administration route: Oral
Retrovir
Administration route: Oral
Indication: HIV Infection
Viracept
Indication: HIV Infection
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-07-12
Patient: male
Adverse reactions / side effects: Drug Prescribing Error, Hepatic Enzyme Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Adverse event in 45 year old male receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-07-06
Patient: 45 year old male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Pneumonia, Acute Respiratory Distress Syndrome, Pancytopenia, Histoplasmosis Disseminated, Pyrexia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Crixivan
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-04
Daraprim
Administration route: Oral
Indication: Cerebral Toxoplasmosis
Start date: 2001-08-25
End date: 2001-08-31
Daraprim
Administration route: Oral
Start date: 2001-09-01
End date: 2001-09-06
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-04
Other drugs received by patient: Epivir; Clindamycin Hydrochloride; Dalacin S; Hydrocortone; Predonine; Predonine; Predonine; Predonine; Glyceol; Glyceol; Glyceol
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-29
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Combivir
Indication: Antiviral Prophylaxis
Start date: 2005-02-17
End date: 2005-04-06
Retrovir
Dosage: 1.1ml twice per day
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2005-04-06
End date: 2005-05-17
Other drugs received by patient: Retrovir; Kaletra
Adverse event in 66 year old male receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-06-27
Patient: 66 year old male
Adverse reactions / side effects: Hypoacusis, Pancytopenia, Otitis Media
Adverse event resulted in: hospitalization
Suspect drug(s):
Baktar
Administration route: Oral
Indication: Pneumocystis Jiroveci Pneumonia
Start date: 2004-11-18
End date: 2006-05-29
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-22
End date: 2006-05-29
Kaletra
Dosage: 6cap per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-22
End date: 2006-05-29
Retrovir
Dosage: 400mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-22
End date: 2004-12-30
Ziagen
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-31
End date: 2006-05-29
Other drugs received by patient: Benambax; Funguard; Glyceol; Decadron; Seishoku; Laxoberon; Magnesium Oxide
Adverse event in receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient:
Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: HIV Infection
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Morphine
Retrovir
Indication: HIV Infection
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Viracept
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: Antiviral Prophylaxis
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-15
Patient: female
Adverse reactions / side effects: Jaundice, Hyperglycaemia, Normochromic Normocytic Anaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Caffeine
Dosage: .2ml per day
Indication: Respiratory Distress
Start date: 2007-04-11
Retrovir
Dosage: .2ml per day
Indication: Antiviral Prophylaxis
Start date: 2007-04-11
Other drugs received by patient: Combivir; Kaletra; Phototherapy; Insulin
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08
Patient: female
Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Fortovase
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Lamivudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Retrovir
Dosage: exposure began in week ten of gestation.
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Videx
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zidovudine
Indication: HIV Infection
Start date: 1997-01-01
End date: 1997-01-01
Zidovudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-08
Patient: female, weighing 3.2 kg (7.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Flatulence, Platelet Count Increased, Blood Ketone Body Present, Hypercholesterolaemia, Malaise, Hepatomegaly, Obesity, Talipes, Hypertriglyceridaemia, Blood Pyruvic Acid Decreased, Oxygen Saturation Decreased, Supraventricular Tachycardia, Anaemia, Polyhydramnios, Tachycardia Foetal, Blood Lactic Acid Increased, Faeces Pale, Hypotonia, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Nevirapine
Indication: Antiviral Prophylaxis
Start date: 1999-09-12
End date: 1999-09-12
Nevirapine
Administration route: Oral
Indication: HIV Infection
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Zidovudine
Indication: Antiviral Prophylaxis
Zidovudine
Indication: HIV Infection
Other drugs received by patient: Ritonavir; Saquinavir; Efavirenz; Didanosine; Stavudine; Ferrostrane; Fluorex; Folic Acid; Uvesterol
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a physician from Germany on 2007-06-04
Patient: male, weighing 101.0 kg (222.2 pounds)
Adverse reactions / side effects: Pancreatitis Acute, Superinfection, Pancreatic Pseudocyst
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir
Administration route: Oral
Start date: 2006-02-15
End date: 2006-03-28
Sustiva
Administration route: Oral
Start date: 2006-02-15
End date: 2006-03-28
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2006-02-15
End date: 2006-03-28
Other drugs received by patient: Atorvastatin Calcium; Pantozol; Multi-Vitamin
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-05-31
Patient: female, weighing 3.2 kg (7.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Hyperlactacidaemia, Anaemia, Flatulence, Supraventricular Tachycardia, Malaise, Hepatomegaly, Obesity, Hypotonia, Neutropenia, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
D4T
Indication: HIV Infection
Invirase
Indication: HIV Infection
Norvir
Indication: Drug USE FOR Unknown Indication
Retrovir
Indication: HIV Infection
Videx
Indication: Drug USE FOR Unknown Indication
Viramune
Indication: HIV Infection
Start date: 1999-09-09
End date: 1999-09-09
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Invirase
Dosage: exposure during gestation.
Norvir
Dosage: exposure during gestation.
Retrovir
Dosage: exposure during delivery.
Start date: 1999-07-02
End date: 1999-07-02
Retrovir
Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
Indication: Prophylaxis
Start date: 1999-07-02
End date: 1999-08-10
Retrovir
Administration route: Oral
Start date: 1999-07-07
End date: 1999-07-18
Videx
Dosage: exposure during gestation.
Zerit
Dosage: exposure during gestation.
Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol
Page 1 Next >>
|
